Lill‐Brith von Arx
Herlev Hospital(DK)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Multiple Myeloma Research and Treatments, Diabetes Management and Education, Dermatology and Skin Diseases
Most-Cited Works
- → The Patient Perspective of Diabetes Care: A Systematic Review of Stated Preference Research(2014)56 cited
- → Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns(2022)41 cited
- → Cardiovascular risk profiles: A cross‐sectional study evaluating the generalizability of the glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials REWIND , LEADER and SUSTAIN ‐6 to the real‐world type 2 diabetes population in the United Kingdom(2021)17 cited
- → Therapeutic inertia related to the injectable glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care(2023)7 cited
- → Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients’ Benefit-Risk Tradeoff Preferences(2017)7 cited
- → Prevalence and Treatment Patterns of Adult Atopic Dermatitis in the UK Clinical Practice Research Datalink(2023)4 cited
- → Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon‐like peptide‐1 receptor agonist therapy in UK primary care: A retrospective, real‐world study(2025)3 cited
- → A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Use in Adults with Migraine in Finland(2025)2 cited
- → Patient Benefit-Risk Preference of Insulin treatment: an Examination of Health Literacy- and Beliefs As Predictors of Preference and Risk Aversion(2015)
- → Characterizing Patients and Treatment Patterns in Moderate-to-severe Atopic Dermatitis in Finland: A Population-based Study Using National Health Data(2025)